Regulatory & Legal

Promising clinical trial results show a new inhaler delivers nicotine as fast as a cigarette, offering a breakthrough for smoking cessation after decades of failure.

InspireSemi schedules a key shareholder update as its Thunderbird I chip, built on RISC-V, aims to challenge NVIDIA and AMD in the AI accelerator market.

Portnox now offers passwordless access for RDP and SSH, tackling the credential theft behind 80% of breaches and accelerating the move away from VPNs.

Axis Communications' new SOC 2 Type 2 certification validates long-term cloud security, raising the standard for trust in the physical security industry.

As AI adoption soars, PwC Canada introduces North America's first Big 4 certification for the ISO 42001 AI standard, aiming to close the trust gap.

New add-on tests from a single blood draw help oncologists avoid toxic chemo reactions and filter out false positives, aiming for safer, smarter cancer care.

With 17 new international pacts, the non-profit now covers over 91% of the global neighboring rights market, simplifying royalty collection for creators.

FibroBiologics' Pete O'Heeron will speak at the H-SPAN summit, highlighting how cell therapy is driving a push for new healthspan legislation.

ARS Pharma's neffy challenges the EpiPen with new data on efficacy, cost-effectiveness, and patient preference, promising a less intimidating allergy emergency.

A new lawsuit claims private equity giant TPG hid implant defects and forced a bankruptcy, leaving thousands of injured patients to pay the price.

A new survey shows most family firms expect a leadership change soon, but few are prepared, creating a high-stakes gap between intent and action.

A new partnership between GeminiBio and Tolemy Bio introduces aiMOS™, an AI-powered service designed to cut costs and boost consistency in cell therapy production.

With a new CEO and stunning clinical data, BOOST Pharma advances a potential game-changer for children with the rare genetic disorder Osteogenesis Imperfecta.

With $4.5M donated last year, MAC's iconic lipstick program has evolved from an AIDS crusade into a global force for racial, gender, and environmental justice.

DFR Gold secures $1.2M in insider loans, pushing total debt to $4.5M. The funds aim to fast-track its Burkina Faso gold project, but is it a vote of confidence or a sign of financial strain?

The advanced nuclear startup's new funding and partnership with Blue Owl signal a major push to solve the massive energy demands of data centers.

As California's insurance market faces historic challenges, a key association marks 35 years of navigating the storm and fostering record growth.

Enanta Pharmaceuticals unveils promising data for EDP-978, an oral drug targeting the root cause of conditions like chronic hives, asthma, and eczema.

FPX Nickel's massive Baptiste project could supply low-carbon nickel for EVs, but it first needs to win over the public and regulators. Here's what's at stake.

A new report reveals dangerous conditions in high school welding labs, risking student safety and worsening Canada's critical skilled trades shortage.